公司资料
Eagle Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- EGRX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.59 USD (+465.59%)
收盘价
最后更新: 2026年8月12日
—
市值
股价为何变动
Current closing-price context is not available for EGRX.
公司概览
业务概览
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on hospital and acute-care products. Its business has historically centered on commercialization of focused injectable or hospital-based medicines.
所在地与行业分类
Eagle is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and hospital care.
商业模式特征
The company depends on product sales, hospital access, and portfolio management. Investors usually watch revenue, execution, and strategic changes.
生物医药行业定位
Eagle occupies a hospital-specialty niche within pharma. It is more commercial than development-stage biotech and tends to respond to product and portfolio developments.
未来催化剂
- Eagle’s catalysts are hospital-product execution and any portfolio update that clarifies the company’s growth path. The market cares about recurring demand and margin discipline.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。